Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial. (Q46591845)
Jump to navigation
Jump to search
scientific article published on 15 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial. |
scientific article published on 15 May 2008 |
Statements
Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial (English)
Teodoro Sava
Evi Comploj
Annamaria Fariello
Fable Zustovich
Romana Segati
Cosimo Sacco
Francesco Valduga
Gianluigi Cetto
Enzo Galligioni